← Back
Data updated: Mar 10, 2026
ZHEJIANG POLY PHARM
Infectious DiseaseRespiratoryDermatology
ZHEJIANG POLY PHARM is a generic drug manufacturer focused on Infectious Disease, Respiratory, Dermatology. Key products include VORICONAZOLE.
2023
Since
6
Drugs
-
Trials
77
Approved (2yr)
Key Drugs
No active drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 33%
2 drugs
Respiratory 17%
1 drugs
Dermatology 17%
1 drugs
Gastroenterology 17%
1 drugs
Neurology 17%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Infectious Disease, Dermatology, Gastroenterology
APOTHECON specialty
Infectious Disease, Dermatology, Gastroenterology, Respiratory
LEDERLE big-pharma
Infectious Disease, Neurology, Dermatology, Respiratory
ABBOTT big-pharma
Infectious Disease, Dermatology, Neurology, Respiratory
GSK big-pharma
Infectious Disease, Respiratory, Neurology
Discontinued (1)
Company Info
- First Approval
- 2023-07-27
- Latest
- 2026-02-23
- Applications
- 7
FDA Sponsor Names
ZHEJIANG POLY PHARMZHEJIANG POLY PHARM CO LTD